Category Archives: BioEngineering

DUBLIN--(BUSINESS WIRE)--The "Global Bio Decontamination Equipment Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

The Global Bio-decontamination Equipment market is expected to reach $224.24 million by 2026 growing at a CAGR of 8.1% from 2018 to 2026.

Factors such as rise in use of these equipments in hospitals and other healthcare institutions and increasing number of government initiatives are driving the market growth. Though, the high expenses of the product, particularly powered and strict government regulations in some countries is projected to inhibit the growth of the market. Moreover, rising number of technological applications may provide ample opportunities for the market growth.

By application, pharmaceutical manufacturing segment acquired significant growth in the market owing to aging population and rising chronic and infectious diseases, the pharmaceutical producers are investing heavily in these equipments. Microbial testing and equipment decontamination can be offered as a value-added service to pharmaceutical manufacturers.

The key vendors mentioned are Bioquell, STERIS Life Science, TOMI Environmental Solutions, Fedegari Group, Howorth Air Technology, JCE Biotechnology, Weike Biological Laboratory, Tailin BioEngineering and Noxilizer.

Key Questions Answered in this Report

Key Topics Covered

1 Market Synopsis

2 Research Outline

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Bio Decontamination Equipment Market, By Product Type

5.1 Introduction

5.2 Type 1

5.3 Type 2

6 Global Bio Decontamination Equipment Market, By Type

6.1 Introduction

6.2 Room Decontamination

6.3 Chamber Decontamination

6.4 Starch Blend with PLA

6.5 Starch-Based

7 Global Bio Decontamination Equipment Market, By Product

7.1 Introduction

7.2 Isolator

7.3 Steam Sterilizers

7.4 Pure Steam & Water Systems

7.5 Washers & Dryers

7.6 VHP Sterilization & Biodecontamination

7.7 Transfer Airlocks

7.8 Vaprox Hydrogen Peroxide

7.9 Incubators

7.10 Containers

8 Global Bio Decontamination Equipment Market, By Application

8.1 Introduction

8.2 Bioscience Research

8.3 Pharmaceutical Manufacturing

8.4 Life Science Industry

8.5 Hospital & Healthcare

8.6 Biomedical

8.7 Vitro Fertilization (IVF)

8.8 Animal Care

8.9 Biotechnological

9 Global Bio Decontamination Equipment Market, By Geography

9.1 Introduction

9.2 North America

9.3 Europe

9.4 Asia-Pacific

9.5 South America

9.6 Middle East & Africa

10 Strategic Benchmarking

11 Vendors Landscape

11.1 Bioquell

11.2 STERIS Life Science

11.3 TOMI Environmental Solutions

11.4 Fedegari Group

11.5 Howorth Air Technology

11.6 JCE Biotechnology

11.7 Weike Biological Laboratory

11.8 Tailin BioEngineering

11.9 Noxilizer

For more information about this report visit https://www.researchandmarkets.com/r/1q2xof

Follow this link:
Global Bio Decontamination Equipment Market, Forecast to 2026: Drivers, Restraints, Opportunities, Developments, Segments & Players -...

Text size: research

Grants Invest in Interdisciplinary Work That May Produce Bigger, Federally Funded Projects

Nov. 21, 2019

The first year of The University of Texas at Dallas seed grant initiative has provided $2.2 million to a diverse range of research and scholarly projects with the aim of providing faculty a springboard to earning larger, highly competitive grants.

The Office of Research program, announced last fall, was conceived by Dr. Joseph Pancrazio, vice president for research, who described it as among the largest such programs in the state.

Research, scholarship and creativity play a key role in our growth as an institution, said Pancrazio, who is also a professor of bioengineering in theErik Jonsson School of Engineering and Computer Science. These programs build upon the interdisciplinary work that is a hallmark of the UTDallas experience for our faculty and students. The hope is that this seed funding leads to new ideas that then become the source for new grant proposals and projects.

Distributions to UTDallas from the National Research University Fund (NRUF), a source of state research funding that the University first qualified for in 2018, freed up resources to create the seed grants.

By investing in our faculty while incentivizing collaboration, we are reinforcing a research culture that will encourage prospective investigators to join our academic community as well as earn a return-on-investment relative to federally sponsored research, Pancrazio said.

The seed grants fall into seven categories and will fund work in seven of the Universitys schools.

The program is overseen by Dr. Nicole Leeper Piquero, Robert E. Holmes Jr. Professor of Criminology, who said the program is an exciting way to invest in faculty and encourage interdisciplinary collaboration.

We offer 10 different ways to support researchers from all across our campus, including opportunities for them to showcase their work with workshops both here at UTDallas as well as in Washington, D.C., said Piquero, who is also associate vice president for research development.

Among the seven programs is the Collaborative Biomedical Research Award (CoBRA), which was specifically designed to stimulate interdisciplinary research between faculty at UTDallas and UTSouthwestern Medical Center. Three projects led by Dr. Danieli Rodrigues, associate professor of bioengineering; Dr. Lloyd Lumata, assistant professor of physics; and Dr. Lawrence Reitzer, professor of biological sciences, each received $250,000.

Lumatas grant supports research to develop biomedical imaging techniques, and Reitzers work focuses on combating urinary tract infections.

Rodrigues said the CoBRA award will enable her team to expand the application of an immune-interactive coating she is developing for titanium orthopedic implants that may reduce the implantation failure rate for diabetic patients.

This initiative will give us the opportunity to generate data that will support development and feasibility demonstrations, helping our team to pursue larger grant opportunities in the future, Rodrigues said. It will also promote interdisciplinary training by enabling UTD graduate students and residents from UTSouthwestern to work together on new ways to boost implant healing in immune-compromised cases.

Another program, called the Major Extramural Grant Award (MEGA), assists researchers who are gathering preliminary data to support their pursuit of individual external grant opportunities of at least $6 million. The two MEGA recipients, Dr. Roderick Heelis, director of the William B. Hanson Center for Space Sciences, and Dr. Bart Rypma, the Meadows Foundation Chair in Behavioral and Brain Sciences, each received $200,000 for their proposals.

The Office of Research invites potential applicants to Proposers Day on Friday, Nov. 22, to learn more about the internal funding opportunities available in the next cycle of seed grant initiatives. Registration is required.

Rypmais investigating brain-imaging techniques, while Heelis work aims to better understand Earths space environment and how it affects areas such as communication, navigation and the reentry of space vehicles. His MEGA project seeks to develop innovative techniques to measure the dynamics of particles and gases in the environment around orbiting satellites.

The experiments we do in space are really expensive. Sponsors like NASA and the Air Force wont give you all the money for a project just based on one proposal, said Heelis, Distinguished Chair in Natural Sciences and Mathematics.

Backing from the University allows us to turn our experiments and our conceptual ideas into real things: Heres the prototype device; here are the results from testing it in the lab, Heelis said. And we can put those forward in our second-phase grant proposal. This gives us a much more competitive chance of winning.

The Office of Research awarded seed grants in seven programs:

Media Contact: Stephen Fontenot, UT Dallas, (972) 883-4405,[emailprotected]or the Office of Media Relations, UT Dallas, (972) 883-2155, [emailprotected]

Read more from the original source:
University's Seed Grant Initiative Helps Researchers' Pursuits Blossom - University of Texas at Dallas

FSM eDigest | November 19. 2019

By By Cori Annapolen Goldberg and Sung W. Park

As food regulatory attorneys, we become somewhat excited when the U.S. Food and Drug Administration (FDA) or the U.S. Department of Agriculture (USDA) issues a new law or policy; we think about how it affects our clients and whether the new law or policy truly promotes the public good. What we often notice, however, is that implementation of such rule or policies often becomes delayed, or an extra grace period is provided for the companies to comply. For example, FDA recently announced that it will not require compliance with the new 2016 nutrition labeling rule until July 1, 2020 for certain companies.[1] Similarly, USDA is also providing a buffer period for enforcement for the bioengineering disclosure rule until January 1, 2022, although the official effective date of the rule is January 1, 2020. Such enforcement discretion or buffer periods can be helpful in ensuring that the changes in laws do not affect business negatively. We have been receiving many questions about these laws and regulations recently. Although the agencies may delay enforcement again, we wanted to take this opportunity (and the extra time) to address a few questions regarding the new upcoming FDA and USDA labeling regulations.

First, the question that we probably receive the most often is: which party is ultimately responsible for ensuring compliance with the new regulations? The modern food supply chain is complex. The majority of food and food ingredients are imported from overseas, sometimes processed in the United States (oftentimes by contract manufacturers), at times repackaged by third-party distributors, and only then finally marketed to the public. This complex supply chain means that deciding who is responsible for regulatory compliance can be difficult because so many parties are involved in the process. The short answer to this question is that theoretically, any party that is responsible for introducing the food into interstate commerce is responsible for correct labeling. This is because federal law[2] prohibits sales, marketing, or distribution of any products that violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations.

In practice, however, FDA is likely to consider certain parties to be more responsible for compliance than others. In fact, FDA mentions some of these examples in its guidance.[3] For example, FDA may consider a private label distributor to be more responsible than the contract manufacturer for labeling compliance because the private label distributor is directly responsible for introducing the product to consumers. On the other hand, FDA states that the supplier of a food ingredient is responsible for the accuracy of the information it provides to the processor if there is no suitable way for the processor to determine nutrient values; this is because here, the supplier is the one that can ensure compliance. While the answer to the question of who is responsible will differ in every case, a good way of solving this issue in advance is to delineate in the contract the regulatory obligations of each party (e.g., label review before the final release of the product). This will help ensure regulatory compliance and in the unfortunate event that any noncompliance is found, the parties will able to resolve the disputes more effectively, hopefully without resorting to costly and lengthy dispute resolution mechanisms.

In addition, we often hear about what exact changes were made to the nutrition labeling rule. FDA made several key changes to nutrition labeling. Importantly, FDA instituted a new requirement for Added Sugarssugars that are added during processing of the food. This is applicable to many types of sugars, including syrups and honey, certain concentrated fruit or vegetable juices, and free-, mono-, or disaccharide forms of sugars (for general changes to the format, please refer to the graphic below graphic from FDA; on the left is the old panel, and on the right is the new panel). Importantly, what many industry members overlook is that the new rule includes record-keeping requirements. For example, records must be kept for 2 years to support the declaration of dietary fiber in the product. Similarly, manufacturers must keep a record of the amount of added sugars in foods that may go through nonenzymatic browning or fermentation, because it may not be technologically possible to distinguish between naturally occurring sugars and added sugars in such circumstances. This may be a particularly important change both from regulatory and consumer litigation perspectives, given that plaintiffs attorneys regularly scrutinize the food labels for any potential sources of lawsuits.

Lastly, although not an FDA requirement, while were on the subject of labeling changes, we would like to note that a new USDA bioengineering labeling requirement will become effective on January 1, 2020,[4] although the agency will not enforce until January 1, 2022. While this might seem far away, the bioengineering disclosure rule may require changes to the product formulations or the supply chain. In short, the USDAs bioengineering labeling rule requires disclosure on whether a product contains detectable genetic materials that have been modified in labs and not found in the nature (i.e., genetic engineering). While certain exemptions exist (e.g., foods subject to the USDA labeling jurisdiction with the predominant ingredient also regulated by the USDA; incidental additives), generally speaking, food containing genetically engineered ingredients will need to disclose such inclusion through graphic or textual messages (e.g., bioengineered food, contains a bioengineered food ingredient, or a symbol). Interestingly, the USDA stated that although the implementation date is January 1, 2020, the agency will begin enforcement on January 1, 2022. While some time remains, companies will want to review this quickly to determine the proper marketing and regulatory strategy given that this may result in formulation changes.

In sum, there is likely to be a sea change in the regulatory environment for food manufacturers, distributors, and marketers because of the new FDA labeling regulations and USDA disclosure rules coming into effect beginning in 2020 through 2022. We understand first-hand from working with our clients how much time, money, and effort it can take to update the labels. While such changes may be challenging at first, manufacturers, distributors, or marketers that embrace and prepare for the changes in advance will be able to minimize the risk of regulatory enforcement and focus their energy on building their business. We would like to invite you to review these rules closely, and begin the preparation. If you have any questions, please do not hesitate to reach out to us.

Cori Annapolen Goldberg, a partner in the ReedSmith Life Sciences Health Industry Group, focuses her practice on FDA regulatory issues for the food, drug, medical device and cosmetic industries across the supply chain, including companies investing in these industries.Sung W. Park is an associate in the Life Sciences Health Industry Group in the Washington D.C. office. His practice focuses on providing regulatory counsel to companies developing, distributing, and marketing FDA-regulated products, and responding to regulatory and administrative enforcement actions by federal and state agencies such as FDA, USDA, and state Attorneys General offices.

References1. http://www.fda.gov/food/food-labeling-nutrition/industry-resources-changes-nutrition-facts-label#Compliance&nbsp.2. The Federal Food, Drug and Cosmetic Act. 21 U.S.C. 301(a).3. FDA Guidance to the Industry, Nutrition and Supplement Facts Labels: Questions and Answers Related to the Compliance Date, Added Sugars, and Declaration of Quantitative Amounts of Vitamins and Minerals: Guidance for Industry (November 2018).4. For certain small food manufacturers, the effective date is January 1, 2021.

The rest is here:
FDA's and USDA's Upcoming New Regulations and the Delays - Food Safety Magazine

Share

Share

Share

Email

A new business intelligence report released by HTF MI with title Global 3D Printing in Medical Applications Market Professional Survey Report 2019 is designed covering micro level of analysis by manufacturers and key business segments. TheGlobal 3D Printing in Medical Applications Market survey analysisoffers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are 3D Systems, Eos GmbH Electro Optical Systems, Nanoscribe, EnvisionTEC & Stratasys.

Whats keeping 3D Systems, Eos GmbH Electro Optical Systems, Nanoscribe, EnvisionTEC & Stratasys Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by HTF MIGet Free Sample Report + All Related Graphs & Charts @:https://www.htfmarketreport.com/sample-report/2210310-global-3d-printing-in-medical-applications-market-4

Market Overview of Global 3D Printing in Medical ApplicationsIf you are involved in the Global 3D Printing in Medical Applications industry or aim to be, then this study will provide you inclusive point of view. Its vital you keep your market knowledge up to date segmented by Applications [Medical Implants, Bioengineering Products, Surgical Guides & Surgical Instruments], Product Types [, Polymers, Ceramics, Metals, Biological Cells, Electron Beam Melting, Laser Beam Melting, Photo Polymerization & Droplet Deposition Manufacturing] and major players. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization according to your requirement.

This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts and investments to maximize growth and profitability. The report presents the market competitive landscape and a consistent in depth analysis of the major vendor/key players in the market.

Furthermore, the years considered for the study are as follows:Historical year 2013-2018Base year 2018Forecast period** 2019 to 2025 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

The titled segments and sub-section of the market are illuminated below:The Study Explore the Product Types of 3D Printing in Medical Applications Market: , Polymers, Ceramics, Metals, Biological Cells, Electron Beam Melting, Laser Beam Melting, Photo Polymerization & Droplet Deposition Manufacturing

Key Applications/end-users of Global 3D Printing in Medical Applications Market: Medical Implants , Bioengineering Products, Surgical Guides & Surgical Instruments

Top Players in the Market are: 3D Systems, Eos GmbH Electro Optical Systems, Nanoscribe, EnvisionTEC & Stratasys

Region Included are: North America, Europe, China, Japan, Southeast Asia & India

Enquire for customization in Report @:https://www.htfmarketreport.com/enquiry-before-buy/2210310-global-3d-printing-in-medical-applications-market-4

Important Features that are under offering & key highlights of the report: Detailed overview of 3D Printing in Medical Applications market Changing market dynamics of the industry In-depth market segmentation by Type, Application etc Historical, current and projected market size in terms of volume and value Recent industry trends and developments Competitive landscape of 3D Printing in Medical Applications market Strategies of key players and product offerings Potential and niche segments/regions exhibiting promising growth A neutral perspective towards 3D Printing in Medical Applications market performance Market players information to sustain and enhance their footprint

Read Detailed Index of full Research Study at @https://www.htfmarketreport.com/reports/2210310-global-3d-printing-in-medical-applications-market-4

Major Highlights of TOC:Chapter One: Global 3D Printing in Medical Applications Market Industry Overview1.1 3D Printing in Medical Applications Industry1.1.1 Overview1.1.2 Products of Major Companies1.2 3D Printing in Medical Applications Market Segment1.2.1 Industry Chain1.2.2 Consumer Distribution1.3 Price & Cost Overview

Chapter Two: Global 3D Printing in Medical Applications Market Demand2.1 Segment Overview2.1.1 APPLICATION 12.1.2 APPLICATION 22.1.3 Other2.2 Global 3D Printing in Medical Applications Market Size by Demand2.3 Global 3D Printing in Medical Applications Market Forecast by Demand

Chapter Three: Global 3D Printing in Medical Applications Market by Type3.1 By Type3.1.1 TYPE 13.1.2 TYPE 23.2 3D Printing in Medical Applications Market Size by Type3.3 3D Printing in Medical Applications Market Forecast by Type

Chapter Four: Major Region of 3D Printing in Medical Applications Market4.1 Global 3D Printing in Medical Applications Sales4.2 Global 3D Printing in Medical Applications Revenue & market share

Chapter Five: Major Companies List

Chapter Six: Conclusion

Buy the Latest Detailed Report @https://www.htfmarketreport.com/buy-now?format=1&report=2210310

Key questions answered Who are the Leading key players and what are their Key Business plans in the Global 3D Printing in Medical Applications market? What are the key concerns of the five forces analysis of the Global 3D Printing in Medical Applications market? What are different prospects and threats faced by the dealers in the Global 3D Printing in Medical Applications market? What are the strengths and weaknesses of the key vendors?

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Author:HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the Accurate Forecast in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their Goals & Objectives.

Contact US :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218[emailprotected]

Connect with us atLinkedIn|Facebook|Twitter

See more here:
3D Printing in Medical Applications Market to Make Great Impact in Near Future by 2025 - Tech Admirers

publication date: Nov. 15, 2019

Michael A. Teitell

Director, UCLA Jonsson Comprehensive Cancer Center

The Latta Endowed Chair in Pathology,

Professor, Departments of Pathology and Laboratory Medicine, Pediatrics, and Bioengineering

As one of the cancer hospitals serving Los Angeles County, the UCLA Jonsson Comprehensive Center has to face the challenge of providing the most sophisticatedand most expensivecare to a largely underserved population.

LA County is large and diverse. We have over 10 million individuals, and about 76% of the total would be considered as underrepresented groups, said Michael A. Teitell, director, UCLA Jonsson Comprehensive Cancer Center, the Latta Endowed Chair in Pathology, and professor at the Departments of Pathology and Laboratory Medicine, Pediatrics, and Bioengineering.

We really try to serve all patients from all walks of life who need specialized services, Teitell said. So, here we have financial assistance policies that we follow that are in compliance with our state law in California for patients who are in need of financial assistance. We have institutional staff in relation to CAR T therapy who work closely with commercial and governmental payers to try to obtain funding on a case-by-case basis.

In a conversation with The Cancer Letter, Teitell spoke about the role of immunotherapyincluding CAR T, which can cost over $450,000 for a single dosein the care UCLA delivers at its hospitals and local practices within its catchment area.

Continue reading Teitell: How immunotherapy became the fourth pillar of cancer care at UCLA

See the original post here:
Teitell: How immunotherapy became the fourth pillar of cancer care at UCLA - The Cancer Letter

Thursday, 21 November 2019, 11:08 amPress Release: Royal Society Te Aparangi

Nineteen new Ng Ahurei a Te Aprangi Fellows andNg Ahurei Honore a Te Aprangi Honorary Fellows have beenelected to the Academy of the Royal Society Te Aprangi fortheir distinction in research and advancement of science,technology or the humanities. They are world leaders in thefollowing topics: improving humanmachine interactions,moral philosophy, autobiographical memory, Pasifika poetry,cross-cultural psychology, Indigenous studies and thepolitics of polar regions. Also, paleobiology, seabedgeology, tectonic and seismic hazards, pollen records,reintroduction biology, mathematical functional analysis,optical physics, stroke, maternal health, bone biology, endof life care and gout.

Being made a Fellow is anhonour that recognises distinction in research, scholarshipor the advancement of knowledge at the highest internationalstandards. Fellows can use the post-nominal FRSNZafter their name to indicate this honour.

Chair ofthe Academy Executive Committee Professor Richard BlaikieFRSNZ says it was pleasing to see new Fellows from a widerange of disciplines and backgrounds.

Thenewly-elected Fellows have made amazing contributions toknowledge in their fields and across disciplinaryboundaries. Their election adds significantly to the breadthand diversity of knowledge held within the Academy; theywill help support the purpose of Te Aprangi to engage withand inform New Zealanders on matters of publicimportance.

On behalf of the Academy andSociety, I heartily congratulate all the new Fellows. Theelection process is rigorous and new Fellows can berightfully proud that their outstanding achievements havebeen recognised by their peers in this way.

Thenew Fellows are:

Associate Professor Mark Sagar,CEO Soul Machines Ltd and Auckland Bioengineering Institute,University of AucklandProfessor Valery Feigin, AucklandUniversity of TechnologyProfessor Caroline Crowther,Liggins Institute, University of AucklandProfessor TimMulgan, University of AucklandDr Philip Barnes,NIWAProfessor Elaine Reese, University ofOtagoAssociate Professor Selina Tusitala Marsh,University of AucklandProfessor Ronald Fischer, VictoriaUniversity of WellingtonProfessor James Crampton, GNSScience and Victoria University of WellingtonProfessorJillian Cornish, University of AucklandProfessor BrendanHokowhitu, University of WaikatoDr Kelvin Berryman, GNSScienceProfessor Merryn Gott, University ofAucklandProfessor Rewi Newnham, Victoria University ofWellingtonProfessor Nicola Dalbeth, University ofAuckland and Auckland District Health BoardProfessorPhilip Seddon, University of OtagoProfessor Astrid anHuef, Victoria University of WellingtonProfessorAnne-Marie Brady, University of Canterbury

TheSociety also announced the election of an Honorary Fellow.The election of Honorary Fellows aims to encourage strongties with leading international scientists and scholars andNew Zealands research community.

The new HonoraryFellow is:

Distinguished Professor John Dudley,University of Bourgogne-Franche Comt France and CNRSresearch institute FEMTO-ST.

Read more onthe new Fellows:

AssociateProfessor Mark Sagar, CEO Soul Machines Ltd and AucklandBioengineering Institute, University ofAucklandMark Sagar is a pioneer in thecomputational modelling of the face. His early worksimulating facial appearance and movement received twoscientific and technical Academy Awards. His later researchhas gone deeper under the skin, simulating facialmusculature, behavioural circuits, and the motivatingcognitive processes. Mark is re-imagining how peopleinteract with technology, humanising it in appearance and inthe way it processes information. By creating interactivemodels of human cognition and emotion, he aims to (1) givenew insights into human nature, exploring how interconnectedneural processing models give rise to intelligent andemotional behaviour; (2) build the foundation for futurehuman-intelligent machine co-operation; and (3) democratiseartificial intelligence by making it intuitive to use in aface-to-face manner by millions.

ProfessorValery Feigin, Auckland University ofTechnologyThe research findings of ValeryFeigin have had profound international impact, changing ourunderstanding of stroke and traumatic brain injuryprevention and epidemiology. His research has hadsignificant implications for health care services, researchplanning and priority setting and significantly has resultedin changes in the World Health Organisation InternationalClassification of Diseases 11th revision. His novel approachto primary stroke prevention through motivationalpopulation-wide intervention (Stroke Riskometer app) hasreceived worldwide recognition. He was awarded the 2015MacDiarmid Medal by Royal Society Te Aprangi inrecognition of his work in this area.

Professor Caroline Crowther, Liggins Institute,University of AucklandCaroline Crowther is amaternal fetal medicine subspecialist recognisedinternationally for her landmark, large, multicentreclinical trials and translation of research findings intoguidelines, practice and policy change, leading to improvedmaternal and perinatal health worldwide. Her work haschanged care for women before preterm birth and for diabetesin pregnancy, and has led to substantially reduced death,disability and cerebral palsy in their newborn babies.Caroline has led significant development of evidence-basedhealth care within New Zealand and Australia and beyond,including establishing the Australian and New ZealandCochrane Pregnancy and Childbirth Satellite and has been anadvisor to the World Health Organisation on maternal andperinatal research priorities and care recommendations.

Professor Tim Mulgan, University ofAucklandTim Mulgan is a significantinternational scholar in moral philosophy and philosophy ofreligion. He is the author of five books and numerousjournal articles and book chapters. He has made originalcontributions to discussions about the demands of morality,our obligations to future people, the moral significance ofclimate change, the purpose of the universe, and our placein the cosmos. Tims work has influenced other scholars inphilosophy, and also in related disciplines includingtheology, development studies, environmental studies,political theory, institutional design and publichealth.

Dr Philip Barnes, NIWAPhilip Barnes is an internationally recognisedmarine scientist who uses geophysical and geological methodsto unlock the secrets of the Earth beneath the seabed. Overthe past three decades, his expansive research into NewZealands undersea environment has revolutionised ourperspective of the fault lines and active tectonic processesthat shape New Zealand and its surrounding seafloor. Hisinsights underpin numerous discoveries regarding the dynamicnature of our tectonic plate boundary. His quantification ofnatural phenomena such as deformation of Earths crust,earthquake variability, fault movements and landslidescontinue to produce science of international and societalrelevance, especially as active plate boundaries dominatethe circum-Pacific rim (Ring of Fire) and pose significantgeohazards.

Professor Elaine Reese,University of OtagoElaine Reese is aworld-leading expert on autobiographical memory. She beganher career with the ground-breaking discovery that the wayin which mothers and young children talk about the past haslong-lasting effects on a childs memory development. Overthe years, she has expanded her research to include studieswith older children and adolescents, tracing the role ofmaternal reminiscing practices in the development ofchildrens narrative skill, self-concept, and wellbeingover significant periods of development. More recently, inwork with Mori families, she has documented howcross-cultural differences in maternal reminiscing arereflected in childrens emerging life stories. Eachdiscovery has set a new bar in the field of developmentalpsychology and has fostered new research in laboratoriesaround the world.

Associate Professor SelinaTusitala Marsh, University of AucklandPoetLaureate and scholar Selina Tusitala Marsh ONZM from theUniversity of Auckland is renowned for her outstandingcreative and scholarly contribution to Pacific literatureand Pacific Literary Studies. A prolific author andaward-winning poet, she has published widely. Her poetry hasappeared on the Top 5 NZ Best Seller List and NZListeners Best 100 Books, in Best New Zealand Poems, inthe prestigious The Poetry Archive (UK), and on the renownedUS Poetry Foundation website. The Commonwealth Poet for2016, Marsh composed and performed a poem for QueenElizabeth II at Westminster Abbey on behalf of theCommonwealth member states. She was appointed New ZealandPoet Laureate (2017-2019). A notable scholar and teacher,and hailing from the islands of Samoa and Tuvalu on hermother's side, Selina has produced a distinctive style ofPacific literary criticism, developed Pacific pedagogies forteaching literature, and mentors Mori and Pacificstudents. Selina was awarded the 2019 Humanities AronuiMedal by Royal Society Te Aprangi in recognition of hercontribution.

Professor Ronald Fischer,Victoria University of WellingtonRonald Fischeris one of the leading cross-cultural psychologists in theworld. His work is interdisciplinary, focussing on theinterplay between cultures and individuals, and hispioneering work has led to major advances in the study ofnorms and values, and the evolutionary functions of ritual.He has won many prestigious awards and is a sought-afterspeaker. He has shown exceptional engagement and leadershipthrough establishing large research networks, serving asassociate editor on international journals, initiatinginternational training PhD programmes, teaching at summerschools, serving on executive boards, and contributing toUnited Nations development programmes.

Professor James Crampton, GNS Science andVictoria University of WellingtonJames Cramptonis the leading authority on New Zealand Cretaceouspaleobiology, biostratigraphy and paleo-environments. Hisresearch informs us about life before the last greatextinction. He is internationally recognised for his diverseresearch including systematic paleontology; morphometrics;physical drivers of evolution; dynamics of diversity;macroecology; biogeography; and biostratigraphy. His work inleading international journals synthesises geological,ecological and macroevolutionary processes, and achieves animpressive level of quantitative and analytical rigour. Inaddition to his contributions to paleobiological theory, hisinnovative methodology and analytical techniques arebecoming widely adopted. Through presentations, print, anddisplay of fossils, he has increased public understandingand appreciation of New Zealands past life andenvironments. He was elected a Fellow of the US-basedPaleontological Society in 2018.

ProfessorJillian Cornish, University of AucklandJillianCornish is an international leader and educator in bonebiology and its application to orthopaedic research. She hasidentified a series of key bone regulatory molecules, thuselucidating important pathways in normal bone biology suchas the close relationship between fat cells and bone cellsas well as providing bone growth factors for potential usein orthopaedics. This work has been recognised by researchawards from the International Combined Orthopaedic ResearchSocieties, the Faculty of Science of the Royal College ofPathologists of Australasia, the New Zealand Society ofEndocrinology, the American Society of Bone and MineralResearch, and the Australia and New Zealand Bone and MineralSociety. Her current orthopaedic collaborations have thepotential to alter clinical outcomes for patients withsevere skeletal injuries and bone cancers.

Professor Brendan Hokowhitu, University ofWaikatoBrendan Hokowhitu (Ngti Pkenga) is apioneering Mori scholar who has helped define the globallynascent field of Indigenous Studies. His intellect,originality in thinking and depth of knowledge aredemonstrated in his expansive publications creating thesub-fields of Indigenous Masculinities, and Indigenous Sportand Physical Education, and are significantly contributingto sub-fields of Indigenous Critical Theory, IndigenousMedia, and Indigenous Wellbeing. He leads the Ageing WellNational Science Challenge Kaumtua Mana Motuhakeproject. Uniquely, he has become the Dean of two IndigenousStudies faculties in two different countries (Canada and NewZealand), which is a testament to his international peerrecognition.

Dr Kelvin Berryman, GNSScienceKelvin Berryman QSO is one of theforemost pioneers and international experts in activetectonics and seismic hazard assessment. His research hasincreased fundamental understanding of the processes andhazards to society associated with plate boundary zones andhe has communicated this knowledge to the public, governmentagency staff and elected officials. He has played a pivotalrole in the response and recovery from the Canterburyearthquakes, bringing research knowledge to the fore indecision-making. He was awarded the Queens Service Orderin 2012 for services to science and Canterbury earthquakerecovery.

Professor Merryn Gott, Universityof AucklandMerryn Gott is internationallyrecognised for the critical social science lens she bringsto addressing what the World Health Organisation describesas one of the most significant public health challengesof the 21st century, namely the need to reduce sufferingat the end of life. Her evidence has informed practice andpolicy in Aotearoa New Zealand, the UK, the United Statesand Canada, ultimately leading to positive impact forpatients and whnau. Her work has also led to theoreticaland methodological advances in palliative care researchinternationally. She directs the only bicultural palliativecare research group internationally, recognised asworld-leading for its equity focus.

Professor Rewi Newnham, Victoria University ofWellingtonRewi Newnham (Ngpuhi) is anoutstanding researcher and educator in studying past andpresent environmental and climatic conditions and modernchanges, primarily through analyses of pollen records(palynology). His wide-ranging work includes studies of NewZealands past climates and their controls and links toglobal climate change, using pollen analysis to determinehuman and volcanic impacts on the environment, andcontemporary effects of pollen on human health. Rewi hasachieved world-wide recognition and has contributed to orco-led international initiatives to determine NewZealands past climates, using these findings to answerglobally-important questions about environmental change. Healso draws on his roots in Ngpuhi iwi to build linksbetween science and mtauranga Mori and to help NewZealanders understand the factors that affect environmentalchange.

Professor Nicola Dalbeth, Universityof Auckland and Auckland District HealthBoardNicola Dalbeth is a rheumatologist andprofessor of medicine who leads a research programme ingout, an arthritis of major relevance to Aotearoa NewZealand. Her work has identified novel mechanisms of diseaseand defined treatment approaches for gout. In addition, shehas led international initiatives to define central conceptsof gout, including nomenclature of disease, disease staging,and outcome measures. Her research in both pharmacologicaland non-pharmacological treatments has been incorporatedinto international gout management guidelines.

Professor Philip Seddon, University ofOtagoPhilip Seddon is an outstandingconservation biologist and founding member of the expandingfield of Reintroduction Biology. His work improves thepractice, scientific underpinnings and success of speciestranslocations globally. He has key leadership roles withinspecialist groups of the International Union forConservation of Nature. His publications, including keypapers in flagship journals such as Nature Ecology &Evolution, Science, Conservation Biology,and Trends in Ecology and Evolution, have shapedinternational conservation policy.

ProfessorAstrid an Huef, Victoria University ofWellingtonAstrid an Huef is a highly regardedpure mathematician working in functional analysis, the typeof analysis that deals with infinite-dimensional phenomena.Her focus ranges broadly from operator algebras associatedwith various dynamical systems, to operator algebrasassociated with combinatorial objects such as graphs andsemigroups, and to purely algebraic analogues of the latter.The breadth, depth and quality of her research isillustrated by her international collaborations, peeresteem, the external funding she has received and thequality of the journals she publishes in.

Professor Anne-Marie Brady, University ofCanterburyThe research of Anne-Marie Brady onAntarctic politics, China's polar interests, and the ChineseCommunist Party's domestic and foreign policy, inparticular, foreign interference activities, has been acatalyst contributing to policy adjustments by governmentsfrom the USA, to New Zealand, Australia, the UK, Canada, andthe EU. Her research has been publicly praised by HillaryClinton and Marco Rubio. Her testimony on Antarctica andChina is recorded in Hansard in the Australian Parliament,as well as in several reports on Antarctica prepared for theAustralian government. Her policy advice helped spark aninquiry into foreign interference in the New Zealandparliament. Her research on small states in the changingglobal order has assisted New Zealand and other small stategovernments with contestable policy advice. She founded agroundbreaking journal of polar social sciences, whichoffers policy relevant research on the Arctic and Antarctic.In 2019, she was awarded the New Zealand Women of InfluenceGlobal Influence Award. She is the first female politicalscientist elected a Fellow of Royal Society Te Aprangi.

HONORARY FELLOW

Distinguished Professor John Dudley, Universityof Bourgogne-Franche Comt FranceJohn Dudleyhas made sustained and exceptional contributions to sciencethrough pioneering research in optical physics and globalscience advocacy. After attending high school in Mangere,South Auckland, he received his PhD from the University ofAuckland in 1992, where he subsequently lectured from 1993to 2000. He then moved to France where he is nowDistinguished Professor at the University ofBurgundy-Franche-Comt and the CNRS research instituteFEMTO-ST. He has made groundbreaking discoveries in thescience of ultrafast lasers, nonlinear optics and extremewaves, with highly cited publications (many of which areco-authored with New Zealand researchers), and numerousinternational awards and distinctions. He is equallycommitted to education, and has initiated major sciencecommunication initiatives with the United Nations and UNESCOthat have reached hundreds of millions worldwide.

Scoop Media

Scoop Citizen Membership ScoopPro for Organisations

View post:
Researchers and scholars at the top of their fields elected - Scoop.co.nz